GSK PLC Sponsored ADR (GSK)
(Delayed Data from NYSE)
$44.98 USD
+0.10 (0.22%)
Updated May 17, 2024 04:00 PM ET
After-Market: $44.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Brokerage Reports
GSK PLC Sponsored ADR [GSK]
Reports for Purchase
Showing records 201 - 220 ( 246 total )
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
DIA/FDA Oligonucleotide-base Therapeutics Conference
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Company: GSK PLC Sponsored ADR
Industry: Large Cap Pharmaceuticals
Griffin Securities Updates Coverage on Ligand Pharma. (LGND)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K